Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.088 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |